 Brian Dillon
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stereotyping | 1 | 2020 | 45 | 0.660 |
Why?
| | Pre-Exposure Prophylaxis | 2 | 2018 | 213 | 0.610 |
Why?
| | Aneurysm, False | 2 | 2008 | 48 | 0.580 |
Why?
| | Prenatal Care | 1 | 2020 | 294 | 0.560 |
Why?
| | Students, Medical | 2 | 2018 | 348 | 0.520 |
Why?
| | Patient Satisfaction | 1 | 2020 | 660 | 0.490 |
Why?
| | Angiography | 2 | 2008 | 207 | 0.350 |
Why?
| | Penis | 1 | 2008 | 36 | 0.300 |
Why?
| | Jugular Veins | 1 | 2008 | 41 | 0.290 |
Why?
| | Hepatic Artery | 1 | 2008 | 62 | 0.290 |
Why?
| | Scrotum | 1 | 2008 | 27 | 0.290 |
Why?
| | Umbilical Arteries | 1 | 2008 | 55 | 0.290 |
Why?
| | Vena Cava Filters | 1 | 2008 | 61 | 0.280 |
Why?
| | Biopsy | 2 | 2008 | 1129 | 0.270 |
Why?
| | Bone Marrow Transplantation | 1 | 2008 | 286 | 0.270 |
Why?
| | Prosthesis Implantation | 1 | 2008 | 153 | 0.270 |
Why?
| | Graft vs Host Disease | 1 | 2008 | 252 | 0.250 |
Why?
| | Embolization, Therapeutic | 1 | 2008 | 229 | 0.250 |
Why?
| | Spinal Cord | 1 | 2008 | 370 | 0.240 |
Why?
| | Argininosuccinate Synthase | 1 | 2004 | 2 | 0.220 |
Why?
| | Citrullinemia | 1 | 2004 | 2 | 0.220 |
Why?
| | Arginine | 2 | 2004 | 271 | 0.220 |
Why?
| | Arginase | 1 | 2002 | 32 | 0.190 |
Why?
| | Hydrolases | 1 | 2002 | 48 | 0.190 |
Why?
| | Age Determination by Skeleton | 1 | 2021 | 18 | 0.180 |
Why?
| | Ultrasonography, Interventional | 3 | 2013 | 141 | 0.180 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 110 | 0.170 |
Why?
| | Radiography | 1 | 2021 | 822 | 0.150 |
Why?
| | Young Adult | 6 | 2020 | 13209 | 0.150 |
Why?
| | Artificial Intelligence | 1 | 2021 | 279 | 0.140 |
Why?
| | Nephrotic Syndrome | 1 | 2018 | 39 | 0.140 |
Why?
| | Racism | 1 | 2020 | 135 | 0.140 |
Why?
| | United States Food and Drug Administration | 1 | 2018 | 208 | 0.140 |
Why?
| | Nitric Oxide | 1 | 2002 | 915 | 0.130 |
Why?
| | Adolescent | 6 | 2021 | 21513 | 0.110 |
Why?
| | Ischemia | 1 | 2018 | 409 | 0.110 |
Why?
| | Macrophages | 1 | 2002 | 1547 | 0.110 |
Why?
| | Lower Extremity | 1 | 2018 | 427 | 0.110 |
Why?
| | Biopsy, Needle | 1 | 2013 | 189 | 0.100 |
Why?
| | Fibrosarcoma | 1 | 2012 | 22 | 0.100 |
Why?
| | Sclerosing Solutions | 1 | 2011 | 11 | 0.090 |
Why?
| | Sclerotherapy | 1 | 2011 | 20 | 0.090 |
Why?
| | Anti-HIV Agents | 1 | 2018 | 778 | 0.090 |
Why?
| | Lymphatic Abnormalities | 1 | 2011 | 19 | 0.090 |
Why?
| | Doxycycline | 1 | 2011 | 62 | 0.090 |
Why?
| | Soft Tissue Neoplasms | 1 | 2012 | 115 | 0.090 |
Why?
| | Peripheral Arterial Disease | 1 | 2018 | 475 | 0.090 |
Why?
| | Hand | 1 | 2012 | 156 | 0.090 |
Why?
| | Humans | 13 | 2021 | 137585 | 0.080 |
Why?
| | Carcinoma | 1 | 2012 | 240 | 0.080 |
Why?
| | Liver Diseases | 1 | 2013 | 315 | 0.080 |
Why?
| | Neoplasms | 1 | 2004 | 2671 | 0.070 |
Why?
| | Punctures | 1 | 2008 | 40 | 0.070 |
Why?
| | Platelet Count | 1 | 2008 | 86 | 0.070 |
Why?
| | Male | 8 | 2021 | 67762 | 0.070 |
Why?
| | Liver Function Tests | 1 | 2008 | 114 | 0.070 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 80 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5778 | 0.070 |
Why?
| | Pregnancy | 1 | 2020 | 6763 | 0.070 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 189 | 0.070 |
Why?
| | Lumbar Vertebrae | 1 | 2008 | 246 | 0.060 |
Why?
| | Contrast Media | 1 | 2008 | 467 | 0.060 |
Why?
| | Female | 7 | 2021 | 73304 | 0.060 |
Why?
| | Diagnosis, Differential | 1 | 2008 | 1483 | 0.050 |
Why?
| | HIV Infections | 1 | 2018 | 2836 | 0.050 |
Why?
| | Child | 5 | 2021 | 21935 | 0.050 |
Why?
| | Pharmacogenetics | 1 | 2004 | 180 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2018 | 10811 | 0.050 |
Why?
| | Tumor Cells, Cultured | 1 | 2004 | 955 | 0.050 |
Why?
| | Nitric Oxide Synthase | 1 | 2002 | 240 | 0.050 |
Why?
| | Radiologists | 1 | 2021 | 51 | 0.040 |
Why?
| | United States | 1 | 2018 | 14841 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2002 | 560 | 0.040 |
Why?
| | Swine | 1 | 2002 | 775 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1738 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1353 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2002 | 789 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2002 | 886 | 0.040 |
Why?
| | Fasciotomy | 1 | 2018 | 12 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 1 | 2008 | 2691 | 0.040 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2018 | 43 | 0.040 |
Why?
| | Infant | 3 | 2021 | 9465 | 0.040 |
Why?
| | Ankle Brachial Index | 1 | 2018 | 37 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2018 | 155 | 0.030 |
Why?
| | Child, Preschool | 3 | 2021 | 11074 | 0.030 |
Why?
| | Thrombolytic Therapy | 1 | 2018 | 142 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2008 | 6079 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1946 | 0.030 |
Why?
| | Cell Line | 1 | 2002 | 2847 | 0.030 |
Why?
| | Heparin | 1 | 2018 | 261 | 0.030 |
Why?
| | Acute Disease | 1 | 2018 | 1007 | 0.030 |
Why?
| | Medication Adherence | 1 | 2018 | 467 | 0.030 |
Why?
| | Liver | 1 | 2002 | 1943 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2018 | 594 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3284 | 0.030 |
Why?
| | Anticoagulants | 1 | 2018 | 664 | 0.030 |
Why?
| | Boston | 1 | 2011 | 91 | 0.020 |
Why?
| | Radiography, Interventional | 1 | 2011 | 116 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7604 | 0.020 |
Why?
| | Mice | 1 | 2002 | 17787 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2013 | 15657 | 0.010 |
Why?
| | Adult | 2 | 2021 | 37929 | 0.010 |
Why?
| | Animals | 1 | 2002 | 36940 | 0.010 |
Why?
|
|
Dillon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|